Cumulative elevation of aPTT predicts time to major bleeding and death in ECMO: A joint longitudinal-survival model
Published online on January 03, 2026
Abstract
Perfusion, Ahead of Print.
IntroductionAnticoagulation management during extracorporeal membrane oxygenation (ECMO) remains an important challenge, with bleeding rates reaching 30%. Activated partial thromboplastin time (aPTT) is the most used biomarker for heparin titration, ...
IntroductionAnticoagulation management during extracorporeal membrane oxygenation (ECMO) remains an important challenge, with bleeding rates reaching 30%. Activated partial thromboplastin time (aPTT) is the most used biomarker for heparin titration, ...